Physical Activity and Protein Supplementation After Bariatric Surgery (PAPAB)
PAPAB
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to determine wether regular physical activity in combination with protein supplementation after bariatric surgery can reduce the loss of muscle mass and wether a computer-assisted exercise program is more effective than a usual exercise program regarding frequency of physical activity, fitness and muscular strength.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 29, 2014
CompletedFirst Posted
Study publicly available on registry
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedOctober 26, 2016
October 1, 2016
1.7 years
April 29, 2014
October 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lean body mass loss expressed as percentage of weight loss [%]
Lean body mass is measured by using body impedance analysis. The content of lean body mass in lost weight is calculated using the lost weight in kg and the lost lean body mass in kg.
At month 6
Secondary Outcomes (4)
Relative weight loss [%]
At month 6
Grip strength [lb]
At month 6
Grip strength endurance [sec]
At month 6
Physical fitness [repetitions per 30 sec] / [distance in meters]
At month 6
Other Outcomes (8)
Blood proteins
At month 6
Urea and creatinine excretion
At month 6
Frequency of exercise
During the whole study period of 6 months
- +5 more other outcomes
Study Arms (4)
Protein and computer-assisted exercise
EXPERIMENTALPatient group which takes daily protein supplements and is advised to do exercise 4 times per week by using Nintendo Wii Balance Board and Wii Fit Plus Software during 6 months after bariatric surgery.
Placebo and computer-assisted exercise
PLACEBO COMPARATORPatient group which takes daily control product and is advised to do exercise 4 times per week by using Nintendo Wii Balance Board and Wii Fit Plus Software during 6 months after bariatric surgery.
Protein and usual exercise
ACTIVE COMPARATORPatient group which takes daily protein supplements and is advised to do exercise 4 times per week by using written exercise instructions during 6 months after bariatric surgery.
Placebo and usual exercise
ACTIVE COMPARATORPatient group which takes daily control product and is advised to do exercise 4 times per week by using written exercise instructions during 6 months after bariatric surgery.
Interventions
Postoperative intake of 25 g per day starting on the first day after hospital discharge until 6 months postoperatively.
Postoperative intake of 25 g per day starting on the first day after hospital discharge until 6 months postoperatively.
Postoperative regular computer-assisted exercise using Nintendo Wii Mini, Nintendo Wii Balance Board and Wii Fit Plus Software. Exercise is advised to be done 4 times per week.
Postoperative regular exercise using written exercise instructions. Exercise is advised to be done 4 times per week.
Eligibility Criteria
You may qualify if:
- Age of 18 - 65 years
- Body weight of ≤ 150 kg
- BMI \> 35 kg/m2
- Indication for laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass. The decision about the type of surgery is performed independent of the study by the surgeons in charge according to the German S3 guideline.
You may not qualify if:
- Kidney diseases of any kind
- Serious gastrointestinal diseases (e.g. Morbus Crohn, Colitis Ulcerosa, etc.)
- Serious musculoskeletal diseases
- Serious heart diseases (Myocardial infarction, stent implantation, stroke, etc.)
- Intake of blood thinning medicine (e.g. ASS, Marcumar, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Hohenheimlead
- University Hospital Tuebingencollaborator
Study Sites (1)
Department of General, Visceral, and Transplant Surgery, University Hospital of Tübingen
Tübingen, 72076, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Alfred Königsrainer, Professor
Department of General, Visceral, and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany
- PRINCIPAL INVESTIGATOR
Tobias Meile, MD
Department of General, Visceral, and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany
- STUDY CHAIR
Stephan C Bischoff, Professor
Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2014
First Posted
May 1, 2014
Study Start
March 1, 2014
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
October 26, 2016
Record last verified: 2016-10